Common Contracts
144 similar Development and License Agreement contracts by Isis Pharmaceuticals Inc, Vital Living Inc, Advancis Pharmaceutical Corp, others
BETWEENDevelopment and License Agreement • May 9th, 2007 • Insulet Corp • Surgical & medical instruments & apparatus • Delaware
BETWEENDevelopment and License Agreement • February 14th, 2007 • Insulet Corp • Delaware
EXHIBIT 10.25 [CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE CONFIDENTIAL PORTIONS HAVE BEEN REDACTED AND ARE DENOTED BY A TRIPLE ASTERISK (***). THE CONFIDENTIAL PORTIONS HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.]...Development and License Agreement • January 30th, 2006 • Rim Semiconductor CO • Services-motion picture theaters • Massachusetts
EXHIBIT 10.287 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDED AND...Development and License Agreement • January 13th, 2006 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
RECITALSDevelopment and License Agreement • September 15th, 2005 • Encore Clean Energy Inc • Services-business services, nec
EXHIBIT 10.5 DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • August 9th, 2005 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
RECITALS:Development and License Agreement • June 28th, 2005 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New Jersey
ARTICLE 1 DEFINITIONSDevelopment and License Agreement • November 24th, 2004 • Algorx Pharmaceuticals Inc • New York
DEVELOPMENT AND LICENSE AGREEMENT dated as of June 3, 2004 BY AND BETWEEN BIOSPECIFICS TECHNOLOGIES CORP. (a Delaware corporation) AND AUXILIUM PHARMACEUTICALS, INC. (A DELAWARE CORPORATION)Development and License Agreement • November 22nd, 2004 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
EXHIBIT 10.3 CONFIDENTIAL TREATMENT REQUESTED BY VITAL LIVING, INC. The portions indicated by [REDACTED*] of this document have been omitted and are filed separately with the Commission DEVELOPMENT AND LICENSE AGREEMENT This Agreement, dated as of...Development and License Agreement • August 13th, 2004 • Vital Living Inc • Pharmaceutical preparations • New York
AMENDMENT NO. 1 to DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • August 13th, 2004 • Vital Living Inc • Pharmaceutical preparations • New York
Exhibit 10.1 DEVELOPMENT AND LICENSE AGREEMENT This Development and License Agreement (the "Agreement") is entered into as of 26th April, 2004 (the "Effective Date"), by and between ATS MEDICAL, INC. and ERYSAVE AB. ATS and ErySave may be referred to...Development and License Agreement • August 9th, 2004 • Ats Medical Inc • Orthopedic, prosthetic & surgical appliances & supplies • England
RECITALSDevelopment and License Agreement • May 17th, 2004 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
ARTICLE 1 DEFINITIONSDevelopment and License Agreement • October 9th, 2003 • Advancis Pharmaceutical Corp • Pharmaceutical preparations • New York
REDACTED COPY DEVELOPMENT AND LICENSE AGREEMENT This Agreement, dated as of December 28, 2001 (the "EFFECTIVE DATE"), by and between e-nutriceuticals, Inc., a Delaware corporation ("E-NUT"), and SkyePharma PLC, a United Kingdom corporation ("SKYE"). W...Development and License Agreement • September 8th, 2003 • Vital Living Inc • Pharmaceutical preparations • New York
EXHIBIT NO. 10.4 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. DEVELOPMENT AND LICENSE AGREEMENT BY AND BETWEEN NITROMED, INC.Development and License Agreement • August 20th, 2003 • Nitromed Inc • Massachusetts
ARTICLE 1 DEFINITIONSDevelopment and License Agreement • August 1st, 2003 • Advancis Pharmaceutical Corp • New York
andDevelopment and License Agreement • March 31st, 2003 • Columbia Laboratories Inc • Pharmaceutical preparations • Delaware
RECITALSDevelopment and License Agreement • November 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
EXHIBIT 10.1 DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • November 14th, 2002 • Cima Labs Inc • Pharmaceutical preparations • New York
EXHIBIT 10.2 DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • August 13th, 2002 • Cima Labs Inc • Pharmaceutical preparations • New York
BACKGROUND ----------Development and License Agreement • June 14th, 2002 • New Visual Corp • Services-motion picture theaters • Massachusetts
OEM-SOFTWARE DEVELOPMENT AND LICENSE AGREEMENT N(degree) 01/01 OEM Software development and License AgreementDevelopment and License Agreement • April 1st, 2002 • Scanvec Amiable LTD • Services-prepackaged software • New York
EXHIBIT 10.18 DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • March 21st, 2002 • Ribapharm Inc • Pharmaceutical preparations • California
RECITALS:Development and License Agreement • December 20th, 2001 • Optical Sensors Inc • Surgical & medical instruments & apparatus • California
Exhibit 2 [*] indicates that a confidential portion of the text of this agreement has been omitted. DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • December 13th, 2001 • Xoma LTD /De/ • Pharmaceutical preparations • New York
AMENDMENT NUMBER ONE TO DEVELOPMENT AND LICENSE AGREEMENT BY AND BETWEENDevelopment and License Agreement • November 14th, 2001 • General Magic Inc • Services-prepackaged software
RECITALS:Development and License Agreement • November 14th, 2001 • Optical Sensors Inc • Surgical & medical instruments & apparatus • California
Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) 200.83 and 240.24b-2 DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • October 11th, 2001 • Isis Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
BETWEENDevelopment and License Agreement • August 29th, 2001 • Isis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
INTRODUCTIONDevelopment and License Agreement • August 14th, 2001 • Tripath Imaging Inc • Laboratory analytical instruments • Delaware
Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) 200.83 and 240.24b-2 DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • August 10th, 2001 • Isis Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
BETWEENDevelopment and License Agreement • August 3rd, 2001 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
SARM RESEARCH, DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • August 2nd, 2001 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
1.8 Devices" means the 40Gb/s devices to be developed pursuant -------- to this Agreement, as described on Exhibit A. --------- 1.9 "Effective Date" means the date of this Agreement as ---------------- indicated above.Development and License Agreement • June 19th, 2001 • Multilink Technology Corp • Semiconductors & related devices • Delaware
